Back to Search Start Over

452O A phase I dose-escalation and expansion study evaluating the safety and efficacy of the MDM2–p53 antagonist BI 907828 in patients (pts) with solid tumours

Authors :
P. Schoeffski
N. Yamamoto
T. Bauer
M. Patel
M.M. Gounder
J. Geng
R. Sailer
G. Jayadeva
P. Lorusso
Source :
Annals of Oncology. 33:S743
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........06cb48e30901e6aa98e796e7f7d65f4b

Tools

Authors Abstract Subjects Details